Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guarneri

Showing results (1241-1250 of 1,433) with videos related to

Pageof 144
Sort By:
The Oncologist|August 21, 2023
Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World SettingLaura Bonanno, Martina Lorenzi, Davide Massa, et al.
Leukemia & Lymphoma|February 12, 2019
Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high riskKoen Van Besien, Lizamarie Bachier-Rodriguez, Michael Satlin, et al.
Frontiers in Oncology|June 28, 2019
Androgen Receptor Expression and Association With Distant Disease-Free Survival in Triple Negative Breast Cancer: Analysis of 263 Patients Treated With Standard Therapy for Stage I-III DiseaseMaria Vittoria Dieci, Vassilena Tsvetkova, Gaia Griguolo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 27, 2026
Multidisciplinary approach to bone metastases: a single center experience in a tertiary cancer centerChiara Pittarello, Antonella Brunello, Evelina Lamberti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2014
Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancerValentina Guarneri, Daniele Giulio Generali, Antonio Frassoldati, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 2024
Long-term patient-reported outcomes from monarchE: Abemaciclib plus endocrine therapy as adjuvant therapy for HR+, HER2-, node-positive, high-risk, early breast cancerSara M Tolaney, Valentina Guarneri, Jae Hong Seo, et al.
Diabetes, Obesity & Metabolism|June 24, 2026
A Four-Week Treatment With Dapagliflozin Is Associated With a Reduction in Insulin-Stimulated Renal Cortical Glucose Uptake: A Post Hoc Analysis From a Pilot StudyShawn Gugliandolo, Cassandra Morciano, Andrea Guarneri, et al.
Breast Cancer Research and Treatment|August 10, 2007
Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancerValentina Guarneri, Antonio Frassoldati, Guido Ficarra, et al.
NPJ Breast Cancer|December 24, 2025
Basal-like HR + /HER2- breast cancers show higher tumor-infiltrating lymphocytes and immune signatures with potential therapeutic implicationsGaia Griguolo, Michele Bottosso, Laia Paré, et al.
Veterinary Research|June 21, 2011
Novel gene expression responses in the ovine abomasal mucosa to infection with the gastric nematode Teladorsagia circumcinctaPamela A Knight, Susan E Griffith, Alan D Pemberton, et al.
Pageof 144

Showing results (1241-1250 of 1,433) with videos related to

Sort By:
Pageof 144
The Oncologist|August 21, 2023
Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World SettingLaura Bonanno, Martina Lorenzi, Davide Massa, et al.
Leukemia & Lymphoma|February 12, 2019
Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high riskKoen Van Besien, Lizamarie Bachier-Rodriguez, Michael Satlin, et al.
Frontiers in Oncology|June 28, 2019
Androgen Receptor Expression and Association With Distant Disease-Free Survival in Triple Negative Breast Cancer: Analysis of 263 Patients Treated With Standard Therapy for Stage I-III DiseaseMaria Vittoria Dieci, Vassilena Tsvetkova, Gaia Griguolo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 27, 2026
Multidisciplinary approach to bone metastases: a single center experience in a tertiary cancer centerChiara Pittarello, Antonella Brunello, Evelina Lamberti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2014
Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancerValentina Guarneri, Daniele Giulio Generali, Antonio Frassoldati, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 2024
Long-term patient-reported outcomes from monarchE: Abemaciclib plus endocrine therapy as adjuvant therapy for HR+, HER2-, node-positive, high-risk, early breast cancerSara M Tolaney, Valentina Guarneri, Jae Hong Seo, et al.
Diabetes, Obesity & Metabolism|June 24, 2026
A Four-Week Treatment With Dapagliflozin Is Associated With a Reduction in Insulin-Stimulated Renal Cortical Glucose Uptake: A Post Hoc Analysis From a Pilot StudyShawn Gugliandolo, Cassandra Morciano, Andrea Guarneri, et al.
Breast Cancer Research and Treatment|August 10, 2007
Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancerValentina Guarneri, Antonio Frassoldati, Guido Ficarra, et al.
NPJ Breast Cancer|December 24, 2025
Basal-like HR + /HER2- breast cancers show higher tumor-infiltrating lymphocytes and immune signatures with potential therapeutic implicationsGaia Griguolo, Michele Bottosso, Laia Paré, et al.
Veterinary Research|June 21, 2011
Novel gene expression responses in the ovine abomasal mucosa to infection with the gastric nematode Teladorsagia circumcinctaPamela A Knight, Susan E Griffith, Alan D Pemberton, et al.
Pageof 144